The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
  • Is CBD ‘Harmful’ to Our Liver? No.
  • Industry Leaders Leading Turnaround in Marijuana Stocks?
Psychedelic Stocks
Exploring the companies and themes that make up this emerging and exciting new sector

Psychedelics Investing 101: Basic Investing Tips

2020-06-29 PSW Editor

Psychedelic drugs are an emerging sector with exciting investment potential. Here are some tips on beginning your due diligence.

Psychedelics Investing 101: Basic Investing Tips

2020-06-29 TSI Editor

Psychedelic drugs are an emerging sector with exciting investment potential. Here are some tips on beginning your due diligence.

Clarmin Explorations Inc. Enters Into Amalgamation Agreement for Reverse Takeover With Cybin Corp.

2020-06-29 PSW Editor

Cybin Corp will become the latest psychedelics company to go public, via RTO.

MindMed Developing IP For Personalized Psychedelic Assisted Therapies

2020-06-24 TSI Reporter

MindMed files patent applications for technologies to screen and optimize dosing of MDMA and LSD.

Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization

2020-06-22 Jeff Nielson

Psychedelics micro-dosing offers several key advantages over psychedelic drug applications centered around heavier dosages.

ATAI Life Sciences Forges Premier Psychedelics R&D Platform

2020-06-19 Jeff Nielson

ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.

Top Canadian Entrepreneur Michael Forbes Joins Board of Directors of PharmaDrug Inc.

2020-06-19 TSI Reporter

PharmaDrug adds depth to its board with new Director who has a wealth of healthcare and addiction-therapy experience.

Champignon Announces Closing of $15 Million Bought Deal Private Placement

2020-06-12 TSI Reporter

Champignon Brands closes on a $15 million financing to expand its clinical psychedelics research programs.

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with University of Wisconsin-Madison

2020-06-12 TSI Reporter

Revive expands on its psychedelics research aimed at addiction treatment.

Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

2020-06-11 TSI Reporter

Numinus becomes the first publicly traded company in Canada to obtain such licensing for psychedelics research.

Will Compass Pathways Be The Next Unicorn?

2020-06-09 TSI Editor

As rumors swirl about Compass Pathways going public, this could become the first psychedelics Unicorn.

MindMed Begins Phase 2 Clinical Trial of LSD for Treating "Suicide Headaches"

2020-06-08 TSI Reporter

MindMed begins a Phase 2 clinical trial of LSD for cluster headaches in Switzerland.

  • Previous
  • 1
  • ...
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

2020-08-31
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

What Does Field Trip Psychedelics Offer Investors?

Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll

Psychedelic Stocks
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2023, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor